5 mins | 30 mins | Hourly | Daily | Weekly |
---|---|---|---|---|
NEUTRAL | NEUTRAL | SELL | SELL | SELL |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MA5 | 7.32▼ | 7.34▼ | 7.34▼ | 6.97▲ | 7.24▼ |
MA10 | 7.13▲ | 7.09▲ | 7.09▲ | 6.88▲ | 8.47▼ |
MA20 | 6.98▲ | 6.93▲ | 6.94▲ | 7.25▼ | 7.76▼ |
MA50 | 7.31▼ | 7.41▼ | 7.52▼ | 9.81▼ | 9.48▼ |
MA100 | 7.76▼ | 8.09▼ | 8.21▼ | 8.10▼ | 82.20▼ |
MA200 | 8.35▼ | 9.41▼ | 10.92▼ | 9.06▼ | 148.10▼ |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MACD | 0.075▲ | 0.090▲ | 0.097▲ | 0.135▲ | 0.457▲ |
RSI | 51.162▲ | 50.935▲ | 49.718▼ | 41.952▼ | 43.890▼ |
STOCH | 77.114 | 73.612 | 73.688 | 48.876 | 8.385▼ |
WILL %R | -42.938 | -42.938 | -42.938 | -52.288 | -90.383▼ |
CCI | 33.532 | 49.090 | 48.696 | 62.660 | -47.254 |
▼ GAP | $LYRA Open Gap Down %2 | Set Alert |
Thursday, August 14, 2025 05:35 AM
Alchelyst, a leading full-service fund administrator for alternative asset managers, and Lyra Client Solutions ("Lyra"), a technology-enabled client servicing organization spun out from Apollo (NYSE: ...
|
Tuesday, August 12, 2025 09:18 PM
Detailed price information for Lyra Therapeutics Inc (LYRA-Q) from The Globe and Mail including charting and trades.
|
Tuesday, August 12, 2025 01:16 PM
Reports Q2 revenue $183,000, consensus $181,250. “The positive results from our ENLIGHTEN 2 trial have enabled us to secure financing and are ...
|
date | open | high | low | close | volume |
---|---|---|---|---|---|
15/08/25 | 6.92 | 7.4199 | 6.81 | 7.05 | 11,104 |
14/08/25 | 7.20 | 7.5247 | 6.80 | 7.10 | 18,384 |
13/08/25 | 6.87 | 7.57 | 6.7001 | 7.29 | 68,346 |
12/08/25 | 6.61 | 6.89 | 6.585 | 6.75 | 14,267 |
11/08/25 | 6.60 | 6.81 | 6.51 | 6.67 | 13,804 |
08/08/25 | 6.73 | 7.08 | 6.56 | 6.70 | 13,037 |
07/08/25 | 7.09 | 7.0969 | 6.70 | 6.89 | 26,777 |
06/08/25 | 6.80 | 6.945 | 6.5502 | 6.78 | 11,825 |
05/08/25 | 6.96 | 7.20 | 6.5441 | 6.75 | 35,002 |
04/08/25 | 6.78 | 7.0804 | 6.6019 | 6.83 | 19,219 |
|
|
||||
|
|
||||
|
|